The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2015
Filed:
Jun. 22, 2012
Applicants:
Gerard Moinet, Orsay, FR;
Gabriel Baverel, Saint Cyr au Mont D'or, FR;
Remi Nazaret, Bourg En Bresse, FR;
Bernard Ferrier, Lyon, FR;
Inventors:
Gerard Moinet, Orsay, FR;
Gabriel Baverel, Saint Cyr au Mont D'or, FR;
Remi Nazaret, Bourg En Bresse, FR;
Bernard Ferrier, Lyon, FR;
Assignee:
METABOLYS, , FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/04 (2006.01); C07D 295/182 (2006.01); C07D 295/192 (2006.01); C07D 295/205 (2006.01); C07D 295/26 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); C07D 295/092 (2006.01); C07D 213/74 (2006.01); C07D 241/20 (2006.01); C07D 277/42 (2006.01); C07D 295/088 (2006.01); C07D 295/096 (2006.01); C07D 295/155 (2006.01); C07D 307/33 (2006.01); C07D 495/04 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 295/092 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); C07D 213/74 (2013.01); C07D 241/04 (2013.01); C07D 241/20 (2013.01); C07D 277/42 (2013.01); C07D 295/088 (2013.01); C07D 295/096 (2013.01); C07D 295/155 (2013.01); C07D 295/182 (2013.01); C07D 295/192 (2013.01); C07D 295/205 (2013.01); C07D 295/26 (2013.01); C07D 307/33 (2013.01); C07D 495/04 (2013.01);
Abstract
The invention relates to a compound of formula (I), where R, R, R, m, n, and Lare as defined in claim, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.